News

Team-based Treatment for First Episode Psychosis Found to be High Value

February 02, 2016

NIH-funded study shows early intervention is more cost-effective than typical care

New analysis from a mental health care study shows that “coordinated specialty care” (CSC) for young people with first episode psychosis is more cost-effective than typical community care. Cost-effectiveness analysis in health care is a way to compare the costs and benefits of two or more treatment options.  While the team-based CSC approach has modestly higher costs than typical care, it produces better clinical and quality of life outcomes, making the CSC treatment program a better value. These findings of this study, funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH), will help guide mental health professionals in their treatment for first episode psychosis.

This new analysis, published online today by Schizophrenia Bulletin, was led by Robert Rosenheck, M.D. , professor of psychiatry and public health at Yale University. It is part of the Recovery After an Initial Schizophrenia Episode (RAISE) initiative also funded by the National Institute of Mental Health. This paper reported on the cost-effectiveness of CSC treatment in the RAISE Early Treatment Program  (RAISE-ETP), a randomized controlled trial headed by John M. Kane, M.D ., professor and chairman, Department of Psychiatry at The Hofstra North Shore-LIJ School of Medicine and The Zucker Hillside Hospital.

Explore More Posts

What Do You Think?

Join the conversation to be the first to respond to Team-based Treatment for First Episode Psychosis Found to be High Value

Click here to join the conversation